Yahui Precision Medicine Fund
17
14M
14
1.89
4
0.18
- Stages of investment
- Areas of investment
Summary
In 2015 was created Yahui Precision Medicine Fund, which is appeared as VC. The venture was found in Asia in China. The main department of described VC is located in the Zhaotong.
For fund there is a match between the location of its establishment and the land of its numerous investments - China. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Diagnostics, Medical Device. Among the most popular portfolio startups of the fund, we may highlight GeneCast Biotechnology, Qitan Technology, Yingsheng Biology.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Yahui Precision Medicine Fund, startups are often financed by Empower Investment, Tsinghua Technology Transfer Fund, Tsinghua Holdings. The meaningful sponsors for the fund in investment in the same round are Matrix Partners China, Hanwang Technology, Cowin Venture. In the next rounds fund is usually obtained by Matrix Partners China, Xiamen C&D Corporation, TMT Investments.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2018.
Investments analytics
Analytics
- Total investments
- 17
- Lead investments
- 4
- Rounds per year
- 1.89
- Follow on index
- 0.18
- Investments by industry
- Health Care (13)
- Biotechnology (10)
- Medical (6)
- Health Diagnostics (6)
- Analytics (2) Show 6 more
- Investments by region
-
- China (16)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 38M
- Group Appearance index
- 0.82
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| GeneCast Biotechnology | 27 Feb 2018 | Biotechnology, Health Care, Health Diagnostics, Medical | Late Stage Venture | 33M | China, Beijing, Dongcheng District |
| Neukio Biotherapeutics | 02 Sep 2022 | Biotechnology | Early Stage Venture | 50M | Shanghai, Shanghai, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.